Oncorena

Rwanda
Byumba, Northern Province, Rwanda

Company profile

Oncorena company profile

Oncorena is a pharmaceutical company that is working on a treatment for advanced kidney cancer (metastatic renal cancer). Its goal is to confirm orellanine's potent anti-tumor activity and other clinical benefits in patients with advanced kidney cancer.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0+
Founded
2011-01-01, Year

Headquarters

Country code
RW
Continent
Africa

Capital profile

Funding and company signals

Funding rounds
3
Total equity funding
$22.9M
Last funding
Series Unknown / $14M / 2025-06-26
Last equity funding
Series Unknown / $14M
Investors
4
Lead investors
2
Founders
1
Articles
15

Founders and investors

Founders

Jenny Nyström

Lead investors

HealthCapPartners for Development investments in Life Sciences

Investors

Fåhraeus Startup and GrowthHealthCapLincPartners for Development investments in Life Sciences